Enanta Pharmaceuticals
ENTA
#7624
Rank
HK$3.08 B
Marketcap
HK$106.24
Share price
1.01%
Change (1 day)
194.70%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -HK$0.6 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are HK$65.32 Million. In 2024 the company made an earning of -HK$0.76 Billion, an increase over its 2023 earnings that were of -HK$1 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.6 Billion-22.2%
2024 -HK$0.76 Billion-23.87%
2023 -HK$1 Billion4.39%
2022 -HK$0.96 Billion-4.4%
2021 -HK$1.01 Billion91.12%
2020 -HK$0.53 Billion-407.13%
2019 HK$0.17 B-78.63%
2018 HK$0.79 B117.97%
2017 HK$0.36 B-574.65%
2016 -HK$77.07 Million-110.83%
2015 HK$0.71 B-4.5%
2014 HK$0.74 B-638.53%
2013 -HK$0.14 Billion-137.98%
2012 HK$0.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.78 B-44,324.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.07 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$51.66 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$36.47 B-6,237.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$175.61 B-29,655.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$73.05 B-12,395.04%๐Ÿ‡บ๐Ÿ‡ธ USA